Apple is making up ground.
On stage. Moving beyond activity tracking, the tech giant announced new Health and Apple Watch features as it takes on a new generation of wearables prioritizing actionable insights.
Watch this. Losing momentum to competitors on late upgrades and scrapped projects, Apple sought to level the playing field with its Series 12 Watch — adding readiness score, more frequent heart rate readings, and HRV scores while leaving out active blood pressure, for now.
All fronts. Equipping its ecosystem for preventative health, Apple partnered with Quest to streamline $119, 50-biomarker blood draws. Connecting to a new Longevity tap in the Health app, it uses AI to decode labs and biometrics for Health Age, its biological age score.
It’s also adding menopause support to Cycle Tracking, including symptom tracking, cycle insights, educational content, and notifications for potential perimenopause.
Scoreboard. Apple’s new features don’t feel new because most rivals have already shipped multiple generations of the sort. But the bigger story is distribution.
As Oura takes 5M users into its IPO and WHOOP eclipses 3M, Apple Watch counts 100M wearers. In a stroke, Apple has matched their specialization with baked-in scale — with a pipeline of novel features and devices to come.
Punchline: Seemingly losing its health lead on innovation, Apple has pulled it back on legacy. For its wearable rivals, the differentiation challenge begins again.
